Xiaodan P. Zhong
Huazhong, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Targeting Integrin β3 in Endothelial Cells Attenuates Cardiac Fibrosis Through the Calcium-Calmodulin-Dependent Protein Kinase IIα- cAMP-Responsive Element Binding Protein 1 Signaling Axis in Pressure Overload-Induced Heart Failure.
Journal: Journal of the American Heart Association
Published: April 22, 2026
Enalaprilat reverses neutrophil polarization imbalance via targeting taurine-STING axis for treatment of diabetic wounds.
Journal: Cell reports. Medicine
Published: September 09, 2025
Integrin β3 Orchestrates Hepatic Steatosis via a Novel CD36-Dependent Lipid Uptake Complex.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 07, 2025
Complement C3 in panvascular disease: a central integrator of immune signaling and vascular remodeling.
Journal: Clinical science (London, England : 1979)
Published: July 15, 2025
Complement C3/C3a-CCL9 feedback loop orchestrates inflammatory crosstalk to accelerate aortic dissection.
Journal: Biochemical pharmacology
Published: June 17, 2025
Targeting the miR-493-5p/OTUB1 axis to mitigate mitochondrial dysfunction in diabetic cardiomyopathy.
Journal: European journal of pharmacology
Published: March 18, 2025
Y-box binding protein 1: A critical target for understanding and treating cardiovascular disease.
Journal: Cellular signalling
Published: March 12, 2025
TIR8 protects against nonalcoholic steatohepatitis by antagonizing lipotoxicity-induced PPARα downregulation and reducing the sensitivity of hepatocytes to LPS.
Journal: Translational research : the journal of laboratory and clinical medicine
Published: March 12, 2024
A novel complement C3 inhibitor CP40-KK protects against experimental pulmonary arterial hypertension via an inflammasome NLRP3 associated pathway.
Journal: Journal of translational medicine
Published: July 07, 2023
ONX0914 inhibition of immunoproteasome subunit LMP7 ameliorates diabetic cardiomyopathy via restraining endothelial-mesenchymal transition.
Journal: Clinical science (London, England : 1979)
Published: July 04, 2023
Last Updated: 09/26/2026